TY - JOUR
T1 - Ablative margins in percutaneous thermal ablation of hepatic tumors
T2 - a systematic review
AU - Verdonschot, K.H.M.
AU - Arts, S.
AU - van den Boezem, P.B.
AU - de Wilt, J.H.W.
AU - Fütterer, J.J.
AU - Stommel, M.W.J.
AU - Overduin, C.G.
N1 - Publisher Copyright:
© 2023 Radboud University Medical Center (Radboudumc). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2023
Y1 - 2023
N2 - Introduction: This study aims to systematically review current evidence on ablative margins and correlation to local tumor progression (LTP) after thermal ablation of hepatocellular carcinoma (HCC) and colorectal liver metastases (CRLM). Methods: A systematic search was performed in PubMed (MEDLINE) and Web of Science to identify all studies that reported on ablative margins (AM) and related LTP rates. Studies were assessed for risk of bias and synthesized separately per tumor type. Where possible, results were pooled to calculate risk differences (RD) as function of AM. Results: In total, 2910 articles were identified of which 43 articles were eligible for final analysis. There was high variability in AM measurement methodology across studies in terms of measurement technique, imaging modalities, and timing. Most common margin stratification was < 5 mm and > 5 mm, for which data were available in 25/43 studies (58%). Of these, all studies favored AM > 5 mm to reduce the risk of LTP, with absolute RD of 16% points for HCC and 47% points for CRLM as compared to AM < 5 mm. Conclusions: Current evidence supports AM > 5 mm to reduce the risk of LTP after thermal ablation of HCC and CRLM. However, standardization of AM measurement and reporting is critical to allow future meta-analyses and improved identification of optimal threshold value for clinical use.
AB - Introduction: This study aims to systematically review current evidence on ablative margins and correlation to local tumor progression (LTP) after thermal ablation of hepatocellular carcinoma (HCC) and colorectal liver metastases (CRLM). Methods: A systematic search was performed in PubMed (MEDLINE) and Web of Science to identify all studies that reported on ablative margins (AM) and related LTP rates. Studies were assessed for risk of bias and synthesized separately per tumor type. Where possible, results were pooled to calculate risk differences (RD) as function of AM. Results: In total, 2910 articles were identified of which 43 articles were eligible for final analysis. There was high variability in AM measurement methodology across studies in terms of measurement technique, imaging modalities, and timing. Most common margin stratification was < 5 mm and > 5 mm, for which data were available in 25/43 studies (58%). Of these, all studies favored AM > 5 mm to reduce the risk of LTP, with absolute RD of 16% points for HCC and 47% points for CRLM as compared to AM < 5 mm. Conclusions: Current evidence supports AM > 5 mm to reduce the risk of LTP after thermal ablation of HCC and CRLM. However, standardization of AM measurement and reporting is critical to allow future meta-analyses and improved identification of optimal threshold value for clinical use.
KW - UT-Hybrid-D
KW - Colorectal liver metastases
KW - Hepatocellular carcinoma
KW - Local tumor progression
KW - Thermal ablation
KW - Ablative margins
UR - http://www.scopus.com/inward/record.url?scp=85170706975&partnerID=8YFLogxK
U2 - 10.1080/14737140.2023.2247564
DO - 10.1080/14737140.2023.2247564
M3 - Review article
C2 - 37702571
AN - SCOPUS:85170706975
SN - 1473-7140
VL - 23
SP - 977
EP - 993
JO - Expert Review of Anticancer Therapy
JF - Expert Review of Anticancer Therapy
IS - 9
ER -